CellType is a Y Combinator W26 company describing itself as an agentic drug company that simulates human biology. It uses foundation models simulating human biology paired with autonomous agents to run complete drug discovery pipelines. Its core technology, Cell2Sentence, converts single-cell biology data into formats that LLMs can learn from, enabling computational drug screening and validation without traditional animal models. The company reports working with top pharmaceutical companies and says it has discovered and validated a novel cancer treatment signal. CellType is based in New York City.
CellType
ActiveThe agentic drug company. We simulate human biology
Total raised
$500K
1 round
Stage
Seed
Jan 2026
Team
1-10
since 2026
Pricing
—
Founded
2026
New York, United States
Agent-ready
—
Foundation models that simulate human biology
Autonomous agents that run end-to-end drug discovery pipelines
Cell2Sentence technology converting single-cell data into LLM-readable formats
Computational drug screening without traditional animal models
In-silico validation of candidate treatment signals
Agentic workflows spanning discovery through validation
Single-cell biology data ingestion and representation
Collaboration capabilities with pharmaceutical partners
12/100
Early
MCP server
Public API
Webhooks
OAuth 2.0
SDKs
No public agent surfaces detected yet.
Jan 2026 Seed $500K ● Y Combinator
Capital network
$500K raised ·1 backer·10 network links
- Backers1
- Shared portfoliocompanies these backers also fund
- Extended networkfunds that co-invest alongside them
Lila Sciences
Building scientific superintelligence and autonomous AI labs for life, chemical and materials sciences.
AI HealthcareAI Infrastructure
Recursion
Pioneering AI-driven solutions in drug discovery to radically improve lives.
AI HealthcareDrug Discovery
Paradigm Health
AI research platform making clinical trials part of routine patient care
AI HealthcareDrug Discovery
Hippocratic AI
Safe AI agents for healthcare
AI Healthcare
Periodic Labs
Creating AI scientists and autonomous laboratories to accelerate scientific discovery, starting with physical sciences.
AI HealthcareResearch Assistants
OpenEvidence
AI medical assistant for clinicians
AI HealthcareResearch Assistants
- What is CellType?
- CellType is an agentic drug discovery company that simulates human biology using foundation models and autonomous agents to run complete drug discovery pipelines.
- What is Cell2Sentence?
- Cell2Sentence is CellType's core technology that converts single-cell biology data into formats LLMs can learn from, enabling computational drug screening and validation.
- Does CellType use animal models?
- Its approach is computational, screening and validating candidates in silico, which the company positions as reducing reliance on traditional animal models.
- Has CellType produced any results?
- The company reports working with top pharmaceutical companies and says it has discovered and validated a novel cancer treatment signal.
Discussion
Sign in to join the discussion.
Sign inExplore more around CellType
Contextual paths to related AI startups, deals and rankings.